Beyond weight and diabetes, GLP-1s appear to slow or reverse fatty liver disease, chronic kidney disease, and osteoarthritis — and may reduce cardiovascular and stroke risk. Some effects appear independent of weight loss, pointing to a possible anti-inflammatory mechanism. Even a physician who approached these drugs with skepticism has been repeatedly surprised by the evidence.